StockDriftsStockDriftsTop 21 Samsara Biocapital LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 31.16% | 6.90M | $379.4M | +0.00%(+0) | $16.44(+219.52%) | 2026-06-30 | |
| ALMS | ALUMIS INC | 14.67% | 6.35M | $178.6M | +0.00%(+0) | $9.73(+160.22%) | 2026-06-30 | |
| MLYS | MINERALYS THERAPEUTICS INC | 13.01% | 5.87M | $158.4M | +0.00%(+0) | $16.02(+60.05%) | 2026-06-30 | |
| SEPN | SEPTERNA INC | 8.66% | 3.15M | $105.5M | +0.00%(+0) | $21.87(+103.51%) | 2026-06-30 | |
| NGNE | NEUROGENE INC | 4.44% | 1.72M | $54.0M | +0.00%(+0) | $21.47(+68.34%) | 2026-06-30 | |
| KLRS | KALARIS THERAPEUTICS INC | 4.31% | 12.88M | $52.4M | -0.52%(-66.91K) | $8.64(-52.80%) | 2026-06-30 | |
| SGP | SPYGLASS PHARMA INC | 3.86% | 2.11M | $47.0M | +0.00%(+0) | $25.91(+1.12%) | 2026-06-30 | |
| STRO | SUTRO BIOPHARMA INC | 2.9% | 1.06M | $35.3M | +0.00%(+0) | $29.92(-31.55%) | 2026-06-30 | |
| IVA | INVENTIVA SA | 1.96% | 6.31M | $23.9M | +21.56%(+1.12M) | $5.12(-10.07%) | 2026-06-30 | |
| JBIO | JADE BIOSCIENCES INC | 1.34% | 736.2K | $16.4M | -24.01%(-232.56K) | $32.45(-23.85%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +19.13% | +69.07% | -21.65% | -70.48% |
| Top 20 Holdings Unweighted | +38.98% | +168.42% | -4.76% | -21.62% |
Samsara Biocapital LLC reports $1.22B in US-listed equity holdings across 24 positions in its most recent 13F filing. Its largest disclosed positions are SRRK (31.2%), ALMS (14.7%) and MLYS (13.0%). The top 20 holdings account for 92.68% of reported assets. Its disclosed equity book has returned +69.07% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Samsara Biocapital LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Samsara Biocapital LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1744967). View Samsara Biocapital LLC’s 13F filings on SEC